Searched for
ONCOLOGY WORKFORCE IN INDIA
Overhaul of drug regulator begins with recruitment plan for 1,500 specialistsIndia's pharmaceutical landscape is on the verge of transformation! The country’s drug regulatory body is gearing up for an overhaul with t...- Cancer burden rising, all hands on the deckIndia faces a critical shortage of cancer specialists. A new rule for the PMJAY scheme now bars experienced oncologists without specific de...
- India is well positioned to attract future investments, says Eli Lilly's Patrik JonssonEli Lilly's Patrik Jonsson urges India to accelerate regulatory review pathways to boost competitiveness, emphasizing the need for data pro...
- India is well positioned to attract future investments: Patrik Jonsson, President, Lilly InternationalEli Lilly's Patrik Jonsson urges India to accelerate regulatory review pathways to boost competitiveness, emphasizing the need for stronger...
- Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 croreSwiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit for Rs 1,446 crore to a consortium led by ChrysCapital. This div...
- AI firms help patients by making diagnostics faster & way cheaperTricog Health has analysed nearly 33 million ECG scans since 2014, using AI to support hospitals and diagnostic centres. Chains like Manipa...
- Novartis bets big on India; looks to grow beyond cost arbitrage to high-value innovationNovartis is significantly expanding its biomedical research and drug development operations in India, positioning it as a key global hub ou...
- Rewriting the health playbook: How Abu Dhabi is scaling AI and digital careAbu Dhabi Global Health Week 2025 spotlights digital health and AI as drivers of personalised, preventive care. Here’s how Abu Dhabi is sho...
- US drugmaker Merck to boost workforce in India, executive saysMerck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employe...
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...
- Indian pharma sector set for 'volume to value leadership' journey in 2023While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of gener...
- Novartis opens new manufacturing plant in Mumbai to make generic cancer drugsSpread across 32,000 sqm, and housing state-of-the-art production technology, the plant is built to cater to export markets. It currently h...
- Our aim is to be among top 10 players in India: Rajiv Malik of MylanThe Nasdaq-listed company will work with the government to expand affordable healthcare for infectious diseases such as HIV and tuberculosi...
- Ayushman plan brilliant move; India needed it, says Rajiv Malik, President, MylanThe Nasdaq-listed company will work with the government to expand affordable healthcare for infectious diseases like HIV and tuberculosis, ...
- ET Startup Awards: Meet the high achieversToday, Google’s Rajan Anandan, Matrix Partners India’s Avnish Bajaj, Times Internet’s Gautam Sinha and Flipkart’s Binny Bansal share their ...
- India makes all Mylan HIV drugs for developing world: Rajiv Malik, President, MylanWe were second to enter the US in the marketing of a generic version of AstraZeneca's heartburn drug Nexium, but we still managed to build ...
- King's College Hospital to set up world-class hospital in Andhra PradeshNaidu said he planned to set up a Museum in Amaravati and get expertise from the British Museum.
- Glenmark eyes 20% growth per annum over the next decadeGlenmark Pharmaceuticals aims to keep growing its base business by 18-20 per cent per annum over the next ten years.
- iLife Discoveries brings over 50 genetic tests to IndiaiLife Discoveries is looking at bringing benefits of genetic tests for providing appropriate diagnostics and treatment options for diseases...
- Eli Lilly aims to be among top 20 pharma companies in India by 2020US-based pharmaceutical major Eli Lilly and Company expects to be among the top 20 drug makers in India by 2020
Load More
